methods were developed for the analysis of cell-free DNA (cfDNA) to identify fetal trisomies, and large clinical validation studies were completed. The first clinical screening tests became ...

11,12 Here we report the performance of a cell-free DNA (cfDNA) blood-based screening test for colorectal cancer in an average-risk population. The ECLIPSE (Evaluation of the ctDNA LUNAR Test in ...

However, screening can be appropriate for some very healthy people who may have an increased risk for cancer. For all these reasons, I don’t recommend the new cell-free DNA cancer screening ...

A new blood test has an 80% accuracy in predicting preterm preeclampsia, according to a study published today, Feb. 12, in the journal Nature Medicine. The condition, which results in over 70,000 ...

The request will be subject to review and may be granted under the conditions of the data providers. In particular, the NIH cancer data access system (CDAS) will be conferred when deidentified PLCO ...

A blood-based test using cell-free DNA had high sensitivity for colorectal ... The US Preventive Services Task Force has recommended that screening for CRC, even when persons are not symptomatic ...

A DNA screening to look for fetal abnormalities can render some unexpected results. According to a new analysis, a cell-free ...

The global cell ... free fetal DNA (cffDNA) testing market is witnessing intense competition, driven by the rising demand for non-invasive prenatal testing (NIPT), advancements in genetic sequencing ...

However, screening can be appropriate for some very healthy people who may have an increased risk for cancer. For all these reasons, I don't recommend the new cell-free DNA cancer screening tests ...